(Q34657943)

3 August 2017

1 reference

title

Transperineal interstitial permanent prostate brachytherapy for carcinoma of the prostate (English)

1 reference

3 August 2017

1 reference

Ian David Pedley

1

1 reference

3 August 2017

1 June 2002

1 reference

3 August 2017

1 reference

3 August 2017

11

1 reference

3 August 2017

1-2

1 reference

3 August 2017

25-34

1 reference

Retropubic Implantation of Iodine 125 in the Treatment of Prostatic Cancer

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

A survey of current clinical practice of permanent prostate brachytherapy in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

A CT-based evaluation method for permanent implants: application to prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Centralized multiinstitutional postimplant analysis for interstitial prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

A dose-response study for I-125 prostate implants

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Salvage surgery or salvage radiotherapy for locally recurrent prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Androgen deprivation with salvage surgery for radiorecurrent prostate cancer: results at 5-year followup

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Prostate specific antigen based disease control following ultrasound guided 125iodine implantation for stage T1/T2 prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Prostate specific antigen-monitored combination radiotherapy for patients with prostate cancer. I-125 implant followed by external-beam radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Relationship between perineural tumor invasion on needle biopsy and radical prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Predictive value of contralateral biopsies in unilaterally palpable prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Urinary morbidity following ultrasound-guided transperineal prostate seed implantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Brachytherapy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Palladium-103 brachytherapy for prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Actuarial disease-free survival after prostate cancer brachytherapy using interactive techniques with biplane ultrasound and fluoroscopic guidance

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Neoadjuvant androgen suppression with radiation in the management of locally advanced adenocarcinoma of the prostate: experimental and clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Radical prostatectomy versus brachytherapy for early-stage prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Radiotherapy options for localized prostate cancer based upon pretreatment serum prostate-specific antigen levels and biochemical control: a comprehensive review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Temporal resolution of urinary morbidity following prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Transrectal ultrasound-guidedinterstitial radiation therapy for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Urinary incontinence in patients who have a TURP/TUIP following prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Biochemical disease-free survival following 125I prostate implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Clinical course of rectal bleeding following I-125 prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Potency after permanent prostate brachytherapy for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

Erectile dysfunction following radical therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900010-5

7 January 2021

10.1016/S0960-7404(02)00010-5

Identifiers

DOI

1 reference

release_2uvbgr4ms5hj5g5xybhvs6arga

3 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2uvbgr4ms5hj5g5xybhvs6arga

24 November 2022

mapped directly with Wikidata item

PubMed ID

12031865

1 reference

PubMed ID

12031865